Literature DB >> 11060053

Detection of immunoglobulin M antibodies to P35 antigen of Toxoplasma gondii for serodiagnosis of recently acquired infection in pregnant women.

Y Suzuki1, R Ramirez, C Press, S Li, S Parmley, P Thulliez, J S Remington.   

Abstract

We examined the efficiency of detection of immunoglobulin M (IgM) antibodies to a 35-kDa antigen (P35) of Toxoplasma gondii for serodiagnosis of acute infection in pregnant women. A double-sandwich enzyme-linked immunosorbent assay (ELISA) with recombinant P35 antigen (P35-IgM-ELISA) was used for this purpose. On the basis of the clinical history and the combination of results from the toxoplasma serological profile (Sabin-Feldman dye test, conventional IgM and IgA ELISAs, and the differential agglutination test), the patients were classified into three groups: group I, status suggestive of recently acquired infection; group II, status suggestive of infection acquired in the distant past; group III, status suggestive of persisting IgM antibodies. Eighteen (90.0%) of 20 serum samples from group I patients were positive by the P35-IgM-ELISA, whereas none of the 33 serum samples from group II patients were positive. Only 4 (25.0%) of 16 serum samples from group III patients were positive by the P35-IgM-ELISA, whereas all these serum samples were positive by the conventional IgM ELISA. These results indicate that demonstration of IgM antibodies against P35 by the P35-IgM-ELISA is more specific for the acute stage of the infection than demonstration of IgM antibodies by the ELISA that uses a whole-lysate antigen preparation. Studies with sera obtained from four pregnant women who seroconverted (IgG and IgM antibodies) during pregnancy revealed that two of them became negative by the P35-IgM-ELISA between 4 and 6 months after seroconversion, whereas the conventional IgM ELISA titers remained highly positive. The P35-IgM-ELISA appears to be useful for differentiating recently acquired infection from those acquired in the distant past in pregnant women.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060053      PMCID: PMC87526     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Determination of anti-Toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (bioMérieux).

Authors:  H Pelloux; E Brun; G Vernet; S Marcillat; M Jolivet; D Guergour; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

2.  False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test.

Authors:  O Liesenfeld; C Press; J G Montoya; R Gill; J L Isaac-Renton; K Hedman; J S Remington
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

4.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 5.  Toxoplasmosis in pregnancy.

Authors:  S Y Wong; J S Remington
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

6.  Duration of IgM antibodies to Toxoplasma gondii after acute acquired toxoplasmosis.

Authors:  Y Naot; D R Guptill; J S Remington
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

7.  Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies.

Authors:  D Harning; J Spenter; A Metsis; J Vuust; E Petersen
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

8.  Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein.

Authors:  V Martin; M Arcavi; G Santillan; M R Amendoeira; E De Souza Neves; G Griemberg; E Guarnera; J C Garberi; S O Angel
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis.

Authors:  Y Naot; J S Remington
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

10.  Evaluation of a recombinant antigen ELISA for the diagnosis of acute toxoplasmosis and comparison with traditional antigen ELISAs.

Authors:  A M Johnson; H Roberts; A M Tenter
Journal:  J Med Microbiol       Date:  1992-12       Impact factor: 2.472

View more
  13 in total

1.  Identification of potential serodiagnostic and subunit vaccine antigens by antibody profiling of toxoplasmosis cases in Turkey.

Authors:  Li Liang; Mert Döşkaya; Silvia Juarez; Ayşe Caner; Algis Jasinskas; Xiaolin Tan; Bettina E Hajagos; Peter J Bradley; Metin Korkmaz; Yüksel Gürüz; Philip L Felgner; D Huw Davies
Journal:  Mol Cell Proteomics       Date:  2011-04-21       Impact factor: 5.911

2.  Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Authors:  Elisa Beghetto; Andrea Spadoni; Luca Bruno; Wilma Buffolano; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Seroreactivity to and avidity for recombinant antigens in toxoplasmosis.

Authors:  Klaus-Ingmar Pfrepper; Gisela Enders; Marion Gohl; Doris Krczal; Harald Hlobil; Doris Wassenberg; Erwin Soutschek
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

4.  The opportunistic pathogen Toxoplasma gondii deploys a diverse legion of invasion and survival proteins.

Authors:  Xing W Zhou; Björn F C Kafsack; Robert N Cole; Phil Beckett; Rong F Shen; Vern B Carruthers
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

5.  A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis.

Authors:  Lucyna Holec-Gąsior; Bartłomiej Ferra; Dorota Drapała; Dariusz Lautenbach; Józef Kur
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

6.  Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  Wilma Buffolano; Elisa Beghetto; Mariassunta Del Pezzo; Andrea Spadoni; Manlio Di Cristina; Eskild Petersen; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women.

Authors:  Josette Ferrandiz; Corinne Mercier; Martine Wallon; Stéphane Picot; Marie-France Cesbron-Delauw; François Peyron
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 8.  Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies.

Authors:  Lucyna Holec-Gasior
Journal:  Clin Vaccine Immunol       Date:  2013-06-19

Review 9.  Diagnosis of toxoplasmosis and typing of Toxoplasma gondii.

Authors:  Quan Liu; Ze-Dong Wang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Parasit Vectors       Date:  2015-05-28       Impact factor: 3.876

10.  Expression and Single-step Purification of GRA8 Antigen of Toxoplasma gondii in Escherichia coli.

Authors:  Jalal Babaie; Mandana Miri; Ghazaleh Sadeghiani; Mehrak Zare; Ghader Khalili; Majid Golkar
Journal:  Avicenna J Med Biotechnol       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.